Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis

Leukemia
C ZhengW Seifarth

Abstract

Despite recent success in the treatment of early-stage disease, blastic phase (BP) of chronic myeloid leukemia (CML) that is characterized by rapid expansion of therapy-refractory and differentiation-arrested blasts, remains a therapeutic challenge. The development of resistance upon continuous administration of imatinib mesylate is associated with poor prognosis pointing to the need for alternative therapeutic strategies and a better understanding of the molecular mechanisms underlying disease progression. To identify transcriptional signatures that may explain pathological characteristics and aggressive behavior of BP blasts, we performed comparative gene expression profiling on CD34+ Ph+ cells purified from patients with untreated newly diagnosed chronic phase CML (CP, n=11) and from patients in BP (n=9) using Affymetrix oligonucleotide arrays. Supervised microarray data analysis revealed 114 differentially expressed genes (P<10(-4)), 34 genes displaying more than two-fold transcriptional changes when comparing CP and BP groups. While 24 of these genes were downregulated, 10 genes, especially suppressor of cytokine signalling 2 (SOCS2), CAMPATH-1 antigen (CD52), and four human leukocyte antigen-related genes were strongly ov...Continue Reading

References

Mar 1, 1990·Tissue Antigens·G HaleH Waldmann
Sep 1, 1987·The American Journal of Medicine·H M KantarjianE J Freireich
Apr 29, 1999·The New England Journal of Medicine·C L Sawyers
Feb 28, 2002·Mathematical Biosciences·Tzu Ming ChuRuss Wolfinger
Mar 29, 2002·Acta Haematologica·Bertil JohanssonFelix Mitelman
Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
Jun 19, 2003·Oncogene·Michal Oskar NowickiTomasz Skorski
Aug 9, 2003·Blood·Agnieszka P SzremskaVeronika Sexl
Oct 1, 2003·The Journal of Biological Chemistry·Sigal TavorH Phillip Koeffler
Feb 26, 2004·Blood·Bruno Calabretta, Danilo Perrotti
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Oct 6, 2004·Genome Biology·Robert C GentlemanJianhua Zhang
Oct 7, 2004·Cancer Biology & Therapy·Leticia B A RangelPatrice J Morin
Jun 3, 2005·Annals of Hematology·Rüdiger HehlmannAndreas Hochhaus
Aug 23, 2005·Leukemia Research·Wing-Yan AuYok-Lam Kwong
Oct 20, 2005·Clinical Lymphoma & Myeloma·Chadi Nabhan
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Markus RuschhauptUlrich Mansmann

❮ Previous
Next ❯

Citations

Oct 29, 2011·Cancer Immunology, Immunotherapy : CII·Michal Smahel
Mar 31, 2011·Current Hematologic Malignancy Reports·Deborah L White, Timothy P Hughes
Oct 9, 2013·The Journal of Experimental Medicine·Marina SchellerAchim Leutz
Oct 2, 2008·Blood·Alfonso Quintás-Cardama, Jorge Cortes
Apr 24, 2014·Molecular Biology International·Walid SasiKefah Mokbel
Mar 14, 2013·Biochimica Et Biophysica Acta·Natasha S BartenevaIvan A Vorobjev
Feb 9, 2011·Leukemia & Lymphoma·Birgitta Mitchell, Michael Deininger
Feb 1, 2009·Expert Review of Hematology·Stefan Schmidt, Dominik Wolf
Sep 1, 2007·Expert Opinion on Medical Diagnostics·Brijesh Arora, Ayalew Tefferi
Nov 8, 2011·Hematology/oncology Clinics of North America·Jamshid S Khorashad, Michael W N Deininger
Sep 25, 2014·American Journal of Hematology·Juan M Alonso-DominguezGareth Gerrard
Sep 30, 2010·Seminars in Hematology·Susan Branford, Timothy P Hughes
Mar 5, 2016·Biomarker Research·Wiltrud PrinzhornWolfgang Seifarth
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Daniela Cilloni, Giuseppe Saglio
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Juan Carlos Hernández-Boluda, Francisco Cervantes
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Richard T Silver
Aug 25, 2009·Best Practice & Research. Clinical Haematology·Agnes S M Yong, Junia V Melo
Oct 25, 2008·Cytokine & Growth Factor Reviews·Julie PiessevauxJan Tavernier
Oct 16, 2015·Blood Cells, Molecules & Diseases·Vladan P ČokićRaj K Puri
Feb 28, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Diana KleinSergij Goerdt
Aug 19, 2015·Drug Development Research·Kasuen KotagamaMarco Mangone
Feb 13, 2014·Molecular Cancer·Katrin K FleischmannAdelbert A Roscher
May 3, 2008·Differentiation; Research in Biological Diversity·Masha SimanovskyHanan Galski
Dec 18, 2013·Leukemia Research·Kimberly J Payne, Sinisa Dovat
Nov 5, 2013·Leukemia Research·Takeshi YamadaH Daniel Lacorazza
Oct 15, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolas NovitzkyShaheen Mowla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.